Comparison between CMR Green Technologies IPO and Molbio Diagnostics IPO.
CMR Green Technologies IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Molbio Diagnostics IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of CMR Green Technologies IPO is up to ₹0.00 Cr whereas the issue size of the Molbio Diagnostics IPO is up to ₹0.00 Cr. The final issue price of CMR Green Technologies IPO is and of Molbio Diagnostics IPO is .
| CMR Green Technologies IPO | Molbio Diagnostics IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹1 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹300.00 Cr | up to ₹200.00 Cr |
| OFS Issue Size | 3,34,14,138 shares | 1,25,56,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
CMR Green Technologies IPO opens on , while Molbio Diagnostics IPO opens on . The closing date of CMR Green Technologies IPO and Molbio Diagnostics IPO is , and , respectively.
CMR Green Technologies IPO P/E ratio is , as compared to Molbio Diagnostics IPO P/E ratio of .
| CMR Green Technologies IPO | Molbio Diagnostics IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials |
| Company Financials (Restated)Molbio Diagnostics Ltd.'s revenue increased by 22% and profit after tax (PAT) rose by 66% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 86.58 | 46.65 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 16.20% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 20.98% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹12.29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 15.23% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
In the CMR Green Technologies IPO Retail Individual Investors (RII) are offered while in Molbio Diagnostics IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in CMR Green Technologies IPO and 0 shares in Molbio Diagnostics IPO.
| CMR Green Technologies IPO | Molbio Diagnostics IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | |
| Market Maker Reservation | 0 shares | |
| QIB | 0 shares | |
| NII | 0 shares | |
| RII | 0 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 0 shares |
CMR Green Technologies IPO subscribed in total, whereas Molbio Diagnostics IPO subscribed .
